Literature DB >> 3308461

Peroxisomal oxidation of L-2-hydroxyphytanic acid in rat kidney cortex.

J P Draye1, F Van Hoof, E de Hoffmann, J Vamecq.   

Abstract

A previously unreported metabolite of mammalian phytanic acid catabolism, 2-oxophytanic acid, was identified by gas chromatography/mass spectrometry analysis. The formation of 2-oxophytanic acid was demonstrated to result from the oxidation of L-2-hydroxyphytanic acid, a reaction catalysed by a rat-kidney-cortex H2O2-generating oxidase. The pH optimum for the L-2-hydroxyphytanate oxidase activity was 8.5 and its apparent Km and Vm were about 0.15 mM and 0.35 mumol min-1 (g tissue)-1, respectively. L-2-Hydroxyisocaproate, a substrate of rat kidney L-alpha-hydroxyacid oxidase type B, inhibited the formation of 2-oxophytanate from L-2-hydroxyphytanic acid. Fractionation studies have indicated that 40% of L-2-hydroxyphytanate oxidase was associated with a particulate fraction and that the activity distribution of the oxidase closely paralleled that of catalase, a well known peroxisomal marker enzyme.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3308461     DOI: 10.1111/j.1432-1033.1987.tb13374.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  3 in total

1.  Accumulation of phytanic acid alpha-oxidation intermediates in Zellweger fibroblasts.

Authors:  R Fingerhut; W Schmitz; E Conzelmann
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

2.  Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders.

Authors:  B T Poll-The; O H Skjeldal; O Stokke; A Poulos; F Demaugre; J M Saudubray
Journal:  Hum Genet       Date:  1989-01       Impact factor: 4.132

3.  Tissue Proteome of 2-Hydroxyacyl-CoA Lyase Deficient Mice Reveals Peroxisome Proliferation and Activation of ω-Oxidation.

Authors:  Youssef Khalil; Sara Carrino; Fujun Lin; Anna Ferlin; Heena V Lad; Francesca Mazzacuva; Sara Falcone; Natalie Rivers; Gareth Banks; Danilo Concas; Carlos Aguilar; Andrew R Haynes; Andy Blease; Thomas Nicol; Raya Al-Shawi; Wendy Heywood; Paul Potter; Kevin Mills; Daniel P Gale; Peter T Clayton
Journal:  Int J Mol Sci       Date:  2022-01-17       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.